Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1699-3055
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy ; day:13 ; month:4 ; year:2017 ; pages:1-8
Clinical and translational oncology ; (13.4.2017), 1-8
- Keyword
-
Krebs
Onkologie
- Creator
-
Aparicio, L. M. A.
- Contributor
-
Fernandez, I. P.
Cassinello, J.
SpringerLink (Online service)
- DOI
-
10.1007/s12094-017-1657-7
- URN
-
urn:nbn:de:1111-2017042915355
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aparicio, L. M. A.
- Fernandez, I. P.
- Cassinello, J.
- SpringerLink (Online service)
Other Objects (12)
Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
Exploiting innate immunity for cancer immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
MAPK-triggered chromatin reprogramming by histone deacetylase in plant innate immunity
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
Exploiting innate immunity for cancer immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
MAPK-triggered chromatin reprogramming by histone deacetylase in plant innate immunity
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity
Mutation of neurotrophic tyrosine receptor kinase can promote pan-cancer immunity and the efficacy of immunotherapy
Exploiting innate immunity for cancer immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Editorial: Women in cancer immunity and immunotherapy
Circular RNAs in tumor immunity and immunotherapy
Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
MAPK-triggered chromatin reprogramming by histone deacetylase in plant innate immunity
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy